Диссертация (1140821), страница 21
Текст из файла (страница 21)
Abdominal besity and the metabolicsyndrome: contribution to global cardiometabolic risk. Arteriosclerosis, Thrombosis,and Vascular Biology 2008 28 1039–1049.58.Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW & Radder JK.Elevated numbers of tissue-factor exposing microparticles correlate with components ofthe metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002106 2442–2447.59.Donath MY, Bцni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA.Cytokine production by islets in health and diabetes: cellular origin, regulation andfunction.
Trends Endocrinol Metab. 2010; 21(5):261–267.60.Dudding T, Heron J, Thakkinstian A, Nurk E, Golding J, Pembrey M, RingSM, Attia J, Scott RJ. Factor V Leiden is associated with pre-eclampsia but not with137fetal growth restriction: a genetic association study and meta-analysis.
J ThrombHaemost. 2008 Nov;6(11):1869-75.61.Dusanov S., Heggen E., Tonstad S. Characteristics of Metabolic Syndromein Morbidly Obese Subjects. Metab Syndr Disord 2016 Aug 11. [Epub ahead of print].62.Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KA,Lopes LC, Neumann I, McDonald SD, Zhang Y, Zhou Q, Akl EA, Jacobsen AF,Santamaría A, Annichino-Bizzacchi JM, Bitar W, Sandset PM, Bates SM. Women'svalues and preferences for thromboprophylaxis during pregnancy: a comparison ofdirect-choice and decision analysis using patient specific utilities.
Thromb Res. 2015Aug;136(2):341-7.63.Ehrenberg HM, Huston-Presley L, Catalano PM. The influence of obesityand gestational diabetes mellitus on accretion and the distribution of adipose tissue inpregnancy. Am J Obstet Gynecol. 2003; 189(4):944–948.64.Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity anddiabetes on the prevalence of macrosomia. Am J Obstet Gynecol.
2004; 191(3):964–968.65.Ehses JA, Bni-Schnetzler M, Faulenbach M, Donath MY. Macrophages,cytokines and beta-cell death in Type 2 diabetes. Biochem Soc Trans. 2008; 36(Pt3):340–342.66.Eichinger S., Hron G., Bialonczyk С. et al. Overweight, obesity, and therisk of recurrent venous thromboembolism. Arch Intern Med. 2008; 168: 1678-1683.67.Faber D.R., de Groot P.G., Visseren F.L. Role of adpose tissue inhaemostasis, coagulation and fibrnolysis. Obes Rev. 2009; 10: 554-563.68.Fay WP, Garg N & Sunkar M. Vascular functions of the plasminogenactivation system.
Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 1231–1237.69.Feresu SA., Wang Y., Dickinson S., Relationship between maternal obesityand prenatal, metabolic syndrome, obstetrical and perinatal complications of pregnancyin Indiana, 2008-2010. BMC Pregnancy Childbirth. 2015 Oct 16;15:266.13870.Franchini M, Lippi G. Factor V Leiden in women: a thrombotic risk factoror an evolutionary advantage? Semin Thromb Hemost. 2011 Apr;37(3):275-9.71.Franchini M, Targher G, Montagnana M & Lippi G. The metabolicsyndrome and the risk of arterial and venousthrombosis. Thrombosis Research; 2008,122 727–735.72.Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med.2008; 359: 938-949.73.Gaspsyryan A.Y., Ayvazyan L., Mikhailidis D.P., Kitas G.D. Mean plateletvolume: a link between thrombosis and inflammation? Curr Pharm Des. 2011; 17: 4758.74.Gherman RB, Goodwin TM, Leung B, et al.
Incidence, 284 AmericanSociety of Hematology clinical characteristics, and timing of objectively diagnosedvenous thromboembolism during pregnancy. Obstet Gynecol. 1999;94:730-734.75.Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in uteroand early-life conditions on adult health and disease. N Engl J Med. 2008; 359(1):61–73.76.Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients withultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259-262.77.Goralski K.B., Sinai C.J. Type 2 diabetes and cardiovascular disease:getting to the fat of the matter. Can J Physiol Pharmacol. 2007; 85: 113-132.78.Gordon M.
Maternal Physiology in Pregnancy. In: Gabbe S, Niebyl J,Simpson J, eds. Normal and problem pregnancies (ed 4th). NYC: ChurchillLivingstone; 2002:63-92.79.Grandone E, Chinni E, Villani M, Sciannamè N, Tiscia GL, Favuzzi G,Cappucci F, Petruzzelli F, Margaglione M. Modulation of factors involved in placentalhaemostasis and angiogenesis by low-molecular-weight-heparins. Arch Gynecol Obstet.2016 Aug 26. [Epub ahead of print].80.Greer I.A.
Risk factors and diagnosis of VTE in pregnancy // Thromb Res2007; 119: Suppl 1:890.13981.Greer IA, Nelson-Piercy C. Low-molecular-weight heparins forthromboprophylaxis and treatment of venous thromboembolism in pregnancy: asystematic review of safety and efficacy. Blood. 2005;106:401-407.82.Gregor M.F., Hotamisligil G.S.
Thematic review series: AdipocyteBiology. Adipocyte stress: the en doplasmic; reticulum and metabolic disease. J .LipidRes. 2007; 48: 1905-1914.83.Gris JC, Mercier E, Quere I, et al. Low-molecular weight heparin versuslow-dose aspirin in women with one fetal loss and a constitutional thrombophilicdisorder. Blood. 2004;103:3695-3699.84.Guerra-Shinohara EM, Bertinato JF, Tosin Bueno C, Cordeiro da Silva K,Burlacchini de Carvalho MH, Pulcineli Vieira Francisco R, Zugaib M, Cerda A, MorelliVM.
Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes areassociated with recurrent pregnancy loss. Thromb Haemost. 2012 Oct;108(4):693-700.85.Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction inobesity, diabetes, and vascular diseases. Eur Heart J. 2008; 29: 2959-2971.86.Hargett CW, Tapson VF. Clinical probability and D-dimer testing: howshould we use them in clinical practice? Semin Respir Crit Care Med. 2008 Feb;29(1):15-24.87.Harskamp RE, Zeeman GG. Preeclampsia: at risk for remotecardiovascular disease. Am J Med Sci. 2007 Oct; 334(4):291-5.88.Hartil K, Vuguin PM, Kruse M, et al.
Maternal substrate utilizationprograms the development of the metabolic syndrome in male mice exposed to high fatin utero. Pediatr Res. 2009; 66(4):368–373.89.Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesityand fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul IntegrComp Physiol. 2010; 299(3):R711–R722.90.Heilmann L, Schorsch M, Hahn T, Fareed J. Antiphospholipid syndromeand pre-eclampsia. Semin Thromb Hemost. 2011 Mar;37(2):141-5.14091.Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venousthromboembolism during pregnancy or postpartum: a 30-year population-based study.Ann Intern Med. 2005;143:697-706.92.Hendler I, Blackwell SC, Bujold E, Treadwell MC, Mittal P, Sokol RJ,Sorokin Y. Suboptimal second-trimester ultrasonographic visualization of the fetal heartin obese women: should we repeat the examination? J Ultrasound Med.
2005Sep;24(9):1205-9.93.Hendler I, Goldenberg RL, Mercer BM, et al, The Preterm PredictionStudy: association between maternal body mass index and spontaneous and indicatedpreterm birth. Am J Obstet Gynecol. 2005, 192: 882-886.94.Hernandez Vera R., Vilahur G., Badimon L. Obesity with insulin resistanceincrease thrombosis in wild-type and bone marrow-transplanted Zucker fatty rats.Thromb Haemost. 2013; 109: 319-327.95.Hernandez Vera R., Vilahur G., Ferrer-Lorente R. et al. Platelets derivedfrom the bone marrow of diabetic animals show deregulated endoplasmic reticulumstress proteins that contribute to increased thrombosis. Arterioscler Thromb Vase Biol.2012; 32: 2141-2148.96.Hillis C, Crowther MA. Acute phase treatment of VTE: Anticoagulation,including non-vitamin K antagonist oral anticoagulants. Thromb Haemost.
2015 Jun;113(6):1193-202. Epub 2015 May 7.97.Hong EG, Ko HJ, Cho YR, et al. Interleukin-10 prevents diet-inducedinsulin resistance by attenuating macrophage and cytokine response in skeletal muscle.Diabetes. 2009; 58(11):2525– 2535.98.Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in theanticoagulated patient: defining the risks (the second ASRA Consensus Conference onNeuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172-197.99.Horvath B, Bodecs T, Boncz I, Bodis J. Metabolic syndrome in normal andcomplicated pregnancies. Metab Syndr Relat Disord. 2013 Jun;11(3):185-8.141100.Hotamisligil GS.
Inflammation and metabolic disorders. Nature. 2006;44(7121):860–867.101.Howie GJ, Sloboda DM, Kamal T, Vickers MH. Maternal nutritionalhistory predicts obesity in adult offspring independent of postnatal diet. J Physiol. 2009;587(Pt 4):905–915.102.Ibanez B., Vilahur G., Badimon J.J. Plaque progression and regression inatherothrombosis. J Thromb Haemost. 2007; 5 (1): 292-299.103.Isenovic ER, Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A,Radak D. Link between Metabolic Syndrome and Insulin Resistance. Curr VascPharmacol.
2016 Oct 7.[Epub ahead of print].104.Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns ofvenous thromboembolism in pregnancy and puerperium—a register-based casecontrolstudy. Am J Obstet Gynecol. 2008;198:233 e231-237.105.James AH. Venous thromboembolism in pregnancy. Arterioscler ThrombVasc Biol. 2009; 29: 326-331.106.James AH, Abel DE, Brancazio LR. Anticoagulants in pregnancy.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
